LOS ANGELES, CA / ACCESSWIRE / March 14, 2017 / Capricor Therapeutics, Inc. (NASDAQ: CAPR) will host a conference call and webcast to discuss fourth quarter and full year 2016 financial results, to be held Wednesday, March 15, 2017 at 4:30 PM Eastern Time.
Live Event Information
To participate, connect approximately 5 to 10 minutes before the beginning of the event.
- Date, Time: March 15, 2017 at 4:30 PM ET
- Toll Free: (866) 682-6100
- International: (862) 255-5401
- Live Webcast: http://www.investorcalendar.com/IC/CEPage.asp?ID=175720 or http://capricor.com/news/events/
If you are unable to participate during the live webcast, the event archive will be available at www.investorcalendar.com or http://capricor.com/news/events/.
About Capricor Therapeutics
Capricor Therapeutics, Inc. (CAPR) is a clinical-stage biotechnology company focused on the discovery, development, and commercialization of first-in-class biological therapies for the treatment of cardiac and other medical conditions. Capricor's lead candidate, CAP-1002, is a cardiac cell therapy that is currently being evaluated for the treatment of heart disease associated with Duchenne muscular dystrophy and myocardial infarction (heart attack). Capricor is exploring the use of CAP-2003, its exosome product candidate, in various therapeutic areas including the treatment of ophthalmic disorders. For additional information, visit www.capricor.com.
SOURCE: Investor Network